Akari Therapeutics, Plc (AKTX)
NASDAQ: AKTX · Real-Time Price · USD
1.300
+0.036 (2.88%)
At close: May 20, 2025, 4:00 PM
1.290
-0.010 (-0.74%)
After-hours: May 20, 2025, 7:03 PM EDT
Akari Therapeutics, Market Cap
Akari Therapeutics, has a market cap or net worth of $37.53 million as of May 20, 2025. Its market cap has increased by 222.19% in one year.
Market Cap
37.53M
Enterprise Value
36.79M
1-Year Change
222.19%
Ranking
Category
Stock Price
$1.30
Market Cap Chart
Since September 28, 2015, Akari Therapeutics,'s market cap has decreased from $291.48M to $37.53M, a decrease of -87.13%. That is a compound annual growth rate of -19.14%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 679.94B |
| Johnson & Johnson | 364.11B |
| AbbVie | 325.05B |
| Novo Nordisk | 282.81B |
| UnitedHealth Group | 264.80B |
| Abbott Laboratories | 234.53B |
| Novartis AG | 213.43B |
| AstraZeneca | 212.39B |